Martin Mendoza, Ph.D., serves as the director of health equity for the All of Us Research Program. In this role, he provides leadership and high-level expertise to improve inclusion and equity in precision medicine and leads the program’s efforts to promote health equity.
Before joining All of Us, Martin led extramural research for minority health in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA). He is a recognized expert in clinical trial diversity and has testified on it before Congress. He is also the primary author of the pivotal FDA guidance recommending that clinical trial sponsors be required to submit a diversity and inclusion plan to FDA. Martin’s original idea and recommendation became federal law in December 2022.
Martin has also served as director of the Division of Policy and Data in the Office of Minority Health in the Office of the Secretary at the U.S. Department of Health and Human Services, as well as in the Division of Clinical Research at the National Institute of Neurological Disorders and Stroke. He conducted his primary research training in the National Cancer Institute’s Pediatric Oncology Branch and helped to map chromosome 7 as part of the Human Genome Project during his tenure at the National Human Genome Research Institute.
Martin is a graduate of the University of Maryland, Baltimore County, and received his Ph.D. in cancer biology from Johns Hopkins University.
